| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4934398 | Psychoneuroendocrinology | 2017 | 27 Pages |
Abstract
Our findings provide evidence suggesting that the metabolic adverse effects of olanzapine may aggravate cognitive dysfunction in patients with schizophrenia through an interaction between BDNF and TNF-alpha.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Chen Zhang, Xinyu Fang, Peifen Yao, Yemeng Mao, Jun Cai, Yi Zhang, Meijuan Chen, Weixing Fan, Wei Tang, Lisheng Song,